2Miyakis S,Lockshin MD,Atsumi T,et al.International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome.J Thromb Haemost,2006,4:295-306.
3Tektonidou MC,Sotsiou F,Nakopoulou L,et al.Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies:prevalence,clinical associations,and long-term outcome.Arthritis Rheum,2004,50:2569-2579.
4Cervera R,Piette JC,Font J,et al.Antiphospholipid syndrome:clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients.Arthritis Rheum,2002,46:1019-1027.
5Munoz-Rodriguez FJ,Font J,et al.Clinical study and follow-up of 100 patients with the antiphospholipid syndrome.Semin Arthritis Rheum,1999,29:182-190.
6Rosove MH,Brewer PM.Antiphospholipid thrombosis:clinical course after the first thrombotic event in 70 patients.Ann Intern Med,1992,117:303-308.
7Cervera R,Boffa MC,Khamashta MA,et al.The Euro-phospho-lipid project:epidemiology of the antiphospholipid syndrome in Europe.Lupus,2009,18:889-893.
8Nochy D,Daugas E,Droz D,et al.The intrarenal vascular lesions associated with primary antiphospholipid syndrome.J Am Soc Nephrol,1999,10:507-518.
9Daugas E,Nochy D,Huong DL,et al.Antiphospholipid syndrome nephropathy in systemic lupus erythematosus.J Am Soc Nephrol,2002,13:42-52.
10Oku K,Atsumi T,Bohgaki M,et al.Complement activation in patients with primary antiphospholipid syndrome.Ann Rheum Dis,2009,68:1030-1035.
